Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
Authors not listed
University of California, San Francisco · 2011
Abstract
Ovarian toxicity is a well-described side effect of traditional chemotherapy in premenopausal women receiving treatment for early stage breast cancer. However, the impact of long-term endocrine therapy on ovarian function is not established, and to our knowledge, has never been directly studied. Understanding the effects of hormone therapy on ovarian aging will help breast cancer patients of reproductive age make more informed and empowered decisions regarding their treatment. The purpose of this study is to explore the relationship between tamoxifen therapy and ovarian aging. Patients will be identified through the UCSF Cancer Registry and California Pacific Medical Center Cancer Registry and will be evaluated based on age and menopausal status. Women who read about the study from clinicaltrials.gov and contact the study coordinator will also be considered for enrollment. The age of menopause onset will be assessed through surveys and will be compared to the accepted national average age of natural menopause. Biomarkers of ovarian reserve will be assessed in premenopausal women between ages 25-45 and will be compared to those of healthy age- and ethnicity-matched premenopausal controls from an ongoing RO1- funded prospective longitudinal ovarian aging (OVA) study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Anonymous. (2011). Investigating the Impact of Tamoxifen Therapy on Ovarian Aging. <em>University of California, San Francisco</em>. https://clinicaltrials.gov/study/NCT01384526
Vancouver
Anonymous. Investigating the Impact of Tamoxifen Therapy on Ovarian Aging. University of California, San Francisco. 2011.
BibTeX
@misc{anon2011Invest,
title = {Investigating the Impact of Tamoxifen Therapy on Ovarian Aging},
author = {Anonymous},
journal = {University of California, San Francisco},
year = {2011},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Experimental Gerontology 2024
Open access · CC-BY
The association of circulating bioenergetic metabolites with healthy human aging
The Journal of Clinical Endocrinology & Metabolism 2020
Open access · OA
Vasomotor Symptoms and Accelerated Epigenetic Aging in the Women’s Health Initiative (WHI)
medRxiv 2026
Preprint · OA
Childhood trauma, accelerated biological aging and chronic pain across two population cohorts
AGE 2013
Open access · OA
Association between endothelial dysfunction and frailty: the Toledo Study for Healthy Aging
University of Michigan 2022
Open access · US-GOV
An Observational Study of Women With Breast Cancer Examining the Effect of Endocrine Therapy on Aging
OvationLab 2025
Open access · US-GOV